Profil
Jonathan R.
Haug is currently Chief Executive Officer at ARMO Biosciences, Inc. and DICE Therapeutics, Inc. He serves as President & Director at Ventyx Biosciences, Inc. starting in 2026, Morphic Holding, Inc., Adverum Biotechnologies, Inc. starting in 2025, Scorpion Therapeutics, Inc., and Atai Beckley, Inc. starting in 2026.
He is also President at Verve Therapeutics, Inc. starting in 2025.
Formerly, Mr. Haug was Chief Executive Officer at Prevail Therapeutics, Inc.
Aktive Positionen von Jonathan Haug
| Unternehmen | Position | Beginn |
|---|---|---|
| ARMO BIOSCIENCES INC | Vorstandsvorsitzender | - |
| DICE THER | Vorstandsvorsitzender | - |
| VERE THER | Präsident | 25.07.2025 |
| ADVERUM BIOTECHNOLOGIES, INC. | Präsident | 09.12.2025 |
| VENTYX BIOSCIENCES, INC. | Präsident | 04.03.2026 |
| MORC HOLD | Präsident | - |
Scorpion Therapeutics, Inc.
Scorpion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops precision oncology therapies for cancer treatment | Präsident | - |
Ehemalige bekannte Positionen von Jonathan Haug
| Unternehmen | Position | Ende |
|---|---|---|
| PREVAIL THERAPEUTICS INC. | Vorstandsvorsitzender | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Adverum Biotechnologies, Inc.
Adverum Biotechnologies, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company that develops gene therapies | Health Technology |
ARMO BioSciences, Inc.
ARMO BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapy for treatment of cancer | Health Technology |
DICE Therapeutics, Inc.
DICE Therapeutics, Inc. BiotechnologyHealth Technology Develops oral immunology and other therapeutic products | Health Technology |
Morphic Holding, Inc.
Morphic Holding, Inc. Pharmaceuticals: MajorHealth Technology Develops oral integrin drugs | Health Technology |
Prevail Therapeutics, Inc.
Prevail Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes therapeutics for neurodegenerative diseases | Health Technology |
Verve Therapeutics, Inc.
Verve Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines to treat patients with cardiovascular disease | Health Technology |
Scorpion Therapeutics, Inc.
Scorpion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops precision oncology therapies for cancer treatment | Health Technology |
Ventyx Biosciences, Inc.
Ventyx Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops oral therapies for patients with autoimmune, inflammatory and neurodegenerative diseases | Health Technology |
















